Peter Morrison, MD
Anesthesiology · Canton, GANPI 1689785073
Payments from drug & device makers
Across 120 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$307
- Forte Bio-pharma LLC$300
- AbbVie$265
- Supernus Pharmaceuticals, Inc.$169
- Collegium Pharmaceutical, Inc.$143
- SPR Therapeutics, Inc$94
- plus $928 from 21 others
What the payments were for
- Food & beverage$2,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $307 |
| Forte Bio-pharma LLC | 16 | $300 |
| AbbVie(2 entities) | 21 | $265 |
| Supernus Pharmaceuticals, Inc. | 8 | $169 |
| Collegium Pharmaceutical, Inc. | 10 | $143 |
| SPR Therapeutics, Inc | 1 | $94 |
| Medtronic | 1 | $94 |
| Lilly USA, LLC | 5 | $93 |
| Idorsia Pharmaceuticals US Inc | 4 | $83 |
| Biohaven Pharmaceuticals, Inc. | 3 | $80 |
| Almatica Pharma LLC | 4 | $66 |
| Eisai Inc. | 3 | $55 |
| Arbor Pharmaceuticals, Inc. | 4 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Hikma Pharmaceuticals USA | 3 | $52 |
| Pfizer | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Redhill Biopharma Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Amgen | 1 | $22 |
| Valinor Pharma, LLC | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Virtus Pharmaceuticals LLC | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$125
How this compares
$2,205 in reported general payments places this provider in the 90th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 94 | $215,912 |
| Xtampza ErOxycodone Myristate | 292 | $183,469 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,018 | $82,460 |
| OxycontinOxycodone Hcl | 89 | $62,790 |
| MovantikNaloxegol Oxalate | 128 | $55,346 |
| Nucynta ErTapentadol Hcl | 37 | $54,225 |
| UbrelvyUbrogepant | 48 | $53,899 |
| Nurtec OdtRimegepant Sulfate | 30 | $43,149 |
| Oxycodone Hcl | 1,899 | $42,182 |
| Fentanyl | 386 | $42,060 |
| SymproicNaldemedine Tosylate | 81 | $35,047 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,540 | $33,805 |
| ProlateOxycodone Hcl/Acetaminophen | 12 | $30,095 |
| Morphine Sulfate ErMorphine Sulfate | 881 | $28,391 |
| BelsomraSuvorexant | 54 | $23,363 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta, Belbuca | $143 | $279,915366 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $307 | $215,91294 claims |
| AbbVieUbrelvy, Qulipta, Savella | $265 | $74,50773 claims |
| Redhill Biopharma Inc.Movantik | $28 | $55,346128 claims |
| PfizerNurtec Odt | $51 | $43,14930 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate | $52 | $31,779247 claims |
| Forte Bio-pharma LLCProlate | $300 | $30,09512 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $36 | $21,41551 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $53 | $12,32820 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $83 | $5,21912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Canton
- Jessica McCounRome$12.4M
- Natalie ClarkeEvans$3.2M
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Roman SnieckinskiAtlanta$328K
- Michael AshmoreAtlanta$214K
- Mauro FaibicherMacon$154K
- Matthew KlopmanAtlanta$84K
- Brett HartKings Bay$63K
- Jessica McCabeJohns Creek$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.